Portal de Periódicos da CAPES

Revisão Acesso aberto Produção Nacional Revisado por pares

BIBTEX RIS

Is There Any Association Between Chronic Periodontitis and Anxiety in Adults? A Systematic Review

2021; Frontiers Media; Volume: 12; Linguagem: Inglês

10.3389/fpsyt.2021.710606

1664-0640

Walessa Alana Bragança Aragão, Deiweson Souza‐Monteiro, Déborah Ribeiro Frazão, Yago Gecy de Sousa Né, Railson de Oliveira Ferreira, Luis Felipe Sarmiento Rivera, Miki Taketomi Saito, Cassiano Kuchenbecker Rösing, Nathália Carolina Fernandes Fagundes, Lucianne Cople Maia, Rafael Rodrigues Lima,

Asthma and respiratory diseases

Periodontitis is a multifactorial disease triggered by dysbiotic biofilms, involving the host's immune response, systemic and behavioral factors, including psychosocial conditions. This systematic review aimed to investigate the possible association between periodontitis and anxiety in adults. Searches were performed in PubMed, Scopus, Web of Science, Lilacs, Cochrane, and OpenGrey databases, without language restrictions, considering studies in adults (P-Participants), with (E-Exposure) and without periodontitis (C- Comparison) in an outcome of association with anxiety (O-outcome). Methodological quality assessment was carried out using the Newcastle-Ottawa protocol for case-control and cross-sectional studies, followed by an analysis of the level of evidence using the GRADE tool. Metanalysis was not performed due to several differences in methods applied by authors in primary studies. Eleven observational studies were selected according to the inclusion criteria from the total of 6,380 studies retrieved from databases. Eight studies demonstrated higher anxiety levels in subjects with periodontitis, among which only one study presented a high risk of bias. The GRADE tool revealed a low level of evidence for the anxiety outcome measured by the State-Trait Anxiety Inventory (STAI), both for case-control and cross-sectional studies. However, since anxiety may affect the quality of life of many subjects, it reinforces the need for further studies that evaluate this association for more extended periods. Clinical Trial Registration: PROSPERO-CRD42020190445.